Sign in
CompletedNo phase

Validation of the Accuracy of a Novel POCT Dry Blood Gas Analyzer in Acute Care Settings

Key facts

Who runs it
Zhujiang Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
216 people enrolled
Started
17 Dec 2024
Ended
30 Jun 2025
Type of study
Observational, 2 groups
Treatments tested
  • Wet Blood Gas Analyzer (ABL90)
  • Dry Blood Gas Analyzer (EG-i30)
Record updated
18 July 2025

Who can take part

Age
28 days and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients who are scheduled to undergo arterial blood gas analysis in the emergency department (ED) or emergency intensive care unit (EICU)

Who cannot take part

  • Patients with a confirmed history of infectious diseases such as hepatitis B, syphilis, HIV/AIDS, etc
  • Patients whose residual blood samples are not tested within the specified time frame after collection
  • Other patients deemed ineligible by the investigator (e.g., samples with contamination or other factors affecting sample quality)

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to validate the performance of the novel POCT dry blood gas analyzer EG-i30, against the currently widely used traditional wet blood gas analyzer, Radiometer ABL90, in acute care settings. The main questions it aims to answer are:

Read full original descriptionShow less

1. How consistent are the results between EG-i30 and ABL90 in acute care settings, including outliers, correlation, linearity, and bias? 2. Whether EG-i30 can be considered a suitable alternative to ABL90 in acute care settings.

Participants will be patients in the emergency department who will undergo simultaneous testing with EG-i30 and ABL90 during their emergency care to assess the performance of EG-i30.

The 2 groups in the trial

  • Group 1: ABL90 Group

    Blood gas and biochemical measurements are performed using the ABL90 blood gas analyzer. The results will be compared with those from the EG-i30 analyzer.

    Treatment: Wet Blood Gas Analyzer (ABL90)

  • Group 2: EG-i30 Group

    Blood gas and biochemical measurements are performed using the EG-i30 blood gas analyzer. The results will be compared with those from the ABL90 analyzer.

    Treatment: Dry Blood Gas Analyzer (EG-i30)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Validation of the Accuracy of a Novel POCT Dry Blood Gas Analyzer in Acute Care Settings:A Cross-Sectional Study
Record updated
18 July 2025